Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2025
Resources
All Resources
2024 Savings Report
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Press Releases
Press Release
Share
Press Release
Apr 30, 2020
| Rachel Schwartz
Pharmaceutical Shipping Costs Spike in Response to Global COVID-19 Pandemic
Press Release
Apr 30, 2020
| Rachel Schwartz
AAM Releases Blueprint for Enhancing the Security of the U.S. Pharmaceutical Supply Chain
Press Release
Mar 24, 2020
| Rachel Schwartz
AAM Statement: Preserving Patient Access to Low-Cost Medicines Through COVID-19 and Beyond
Press Release
Feb 24, 2020
| Rachel Schwartz
AAM and the Biosimilars Council Applaud FDA’s Release of Enhanced Purple Book
Press Release
Feb 20, 2020
| Rachel Schwartz
Insurers Fail to Get New Generics to America’s Patients
Press Release
Feb 13, 2020
| Rachel Schwartz
Avalere Analysis Finds Medicare Part D Patients Are Paying More For Their Lower-Cost Generics
Press Release
Feb 10, 2020
| Rachel Schwartz
AAM Statement on Resignation of Chip Davis
Press Release
Feb 6, 2020
| Rachel Schwartz
AAM Announces 2020 Associate Members
Press Release
Feb 6, 2020
| Rachel Schwartz
AAM Announces 2020 Board of Directors
Press Release
Feb 5, 2020
| Rachel Schwartz
The Association for Accessible Medicines Wins Public Affairs Council’s Innovations in Public Affairs Award
Press Release
Jan 29, 2020
| Rachel Schwartz
AAM Statement on Signing USMCA into Law
Press Release
Jan 23, 2020
| Rachel Schwartz
AAM Statement on Avalere Analysis of Generic Substitution
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2025
Resources
All Resources
2024 Savings Report
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action